Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-06-23
2:32 pm
Sale
13DMirum Pharmaceuticals, Inc.
MIRM
New Enterprise Associates 16 L.P.2,186,243
5.8%
-2,000,000decrease
(-47.78%)
View
2022-10-28
4:48 pm
Unchanged
13DAkouos, Inc.
AKUS
New Enterprise Associates 16 L.P.4,294,207
11.6%
0
(Unchanged)
View
2022-10-11
2:01 pm
Purchase
13DAllakos Inc.
ALLK
New Enterprise Associates 16 L.P.6,147,260
7.3%
6,147,260increase
(New Position)
View
2022-05-27
4:34 pm
Sale
13DGenocea Biosciences, Inc.
GNCA
New Enterprise Associates 16 L.P.0
0%
-15,414,495decrease
(Position Closed)
View
2022-04-25
5:04 pm
Purchase
13DTrevi Therapeutics, Inc.
TRVI
New Enterprise Associates 16 L.P.14,370,376
42.5%
6,580,526increase
(+84.48%)
View
2022-01-05
2:42 pm
Sale
13DMetacrine, Inc.
MTCR
New Enterprise Associates 16 L.P.0
0%
-3,060,527decrease
(Position Closed)
View
2021-11-02
09:09 am
Purchase
13DTrevi Therapeutics, Inc.
TRVI
New Enterprise Associates 16 L.P.7,789,850
36.1%
1,851,852increase
(+31.19%)
View
2021-04-13
7:08 pm
Sale
13DGenocea Biosciences, Inc.
GNCA
New Enterprise Associates 16 L.P.15,414,495
26.3%
-1,558,333decrease
(-9.18%)
View
2021-03-26
10:38 am
Purchase
13DMarker Therapeutics, Inc.
MRKR
New Enterprise Associates 16 L.P.14,464,285
17.4%
14,464,285increase
(New Position)
View
2021-03-10
8:35 pm
Sale
13DAllakos Inc.
ALLK
New Enterprise Associates 16 L.P.0
0%
-2,266,675decrease
(Position Closed)
View
2020-09-28
2:18 pm
Purchase
13DMetacrine, Inc.
MTCR
New Enterprise Associates 16 L.P.3,060,527
11.8%
3,060,527increase
(New Position)
View
2020-08-03
2:22 pm
Purchase
13DGenocea Biosciences, Inc.
GNCA
New Enterprise Associates 16 L.P.16,972,828
48.7%
8,004,211increase
(+89.25%)
View
2020-07-07
2:00 pm
Purchase
13DAkouos, Inc.
AKUS
New Enterprise Associates 16 L.P.4,294,207
13.2%
4,294,207increase
(New Position)
View
2020-04-16
4:26 pm
Purchase
13DTrevi Therapeutics, Inc.
TRVI
New Enterprise Associates 16 L.P.5,937,998
33.3%
1,499,436increase
(+33.78%)
View
2020-02-13
10:51 am
Purchase
13DBlack Diamond Therapeutics, Inc.
BDTX
New Enterprise Associates 16 L.P.3,448,757
9.6%
3,448,757increase
(New Position)
View
2019-07-30
3:08 pm
Purchase
13DMirum Pharmaceuticals, Inc.
MIRM
New Enterprise Associates 16 L.P.4,186,243
18.2%
4,186,243increase
(New Position)
View
2019-06-28
4:43 pm
Sale
13DGenocea Biosciences, Inc.
GNCA
New Enterprise Associates 16 L.P.8,968,617
34.1%
-40,975,052decrease
(-82.04%)
View
2019-05-28
4:53 pm
Sale
13DX4 Pharmaceuticals, Inc.
XFOR
New Enterprise Associates 16 L.P.0
0%
-2,000,000decrease
(Position Closed)
View
2019-05-20
1:52 pm
Purchase
13DTrevi Therapeutics, Inc.
TRVI
New Enterprise Associates 16 L.P.4,438,562
25%
4,438,562increase
(New Position)
View
2019-02-22
2:50 pm
Purchase
13DGenocea Biosciences, Inc.
GNCA
New Enterprise Associates 16 L.P.49,943,669
49.1%
12,443,669increase
(+33.18%)
View
Goto 0, 1, Next